AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.27B |
| 2 |
Visa
V
|
+$459M |
| 3 |
Nike
NKE
|
+$410M |
| 4 |
Etsy
ETSY
|
+$311M |
| 5 |
Gen Digital
GEN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$606M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$492M |
| 3 |
Procter & Gamble
PG
|
+$389M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$310M |
| 5 |
IQVIA
IQV
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.23% |
| 2 | Healthcare | 14.38% |
| 3 | Consumer Discretionary | 13.88% |
| 4 | Financials | 12.81% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
2701
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $646K | ﹤0.01% |
32,370
+8,100
| +33% | +$161K |
|
|
SPNE
2702
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $646K | ﹤0.01% |
31,500
+1,900
| +6% | +$39.1K |
|
|
GOCO
2703
DELISTED
GoHealth
GOCO
| $644K | ﹤0.01% |
3,830
+1,392
| +57% | +$244K |
|
|
BMTC
2704
DELISTED
Bryn Mawr Bank Corp
BMTC
| $642K | ﹤0.01% |
15,214
-2,200
| -13% | -$101K |
|
2705
Keros Therapeutics
KROS
$199M
| $641K | ﹤0.01% |
15,100
+1,500
| +11% | +$81.3K |
|
2706
Kelly Services Class A
KELYA
$514M
| $640K | ﹤0.01% |
26,718
+8,106
| +44% | +$200K |
|
2707
Schneider National
SNDR
$6.26B
| $639K | ﹤0.01% |
29,345
-2,400
| -8% | -$58.1K |
|
|
GDEN
2708
DELISTED
Golden Entertainment
GDEN
| $636K | ﹤0.01% |
14,200
-100
| -0.7% | -$3.82K |
|
|
HMNF
2709
DELISTED
HMN Financial Inc
HMNF
| $636K | ﹤0.01% |
29,877
+14,326
| +92% | +$296K |
|
2710
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $634K | ﹤0.01% |
+9,675
| New | +$661K |
|
2711
Alaunos Therapeutics
TCRT
$4.59M
| $634K | ﹤0.01% |
1,602
+150
| +10% | +$70K |
|
2712
ANI Pharmaceuticals
ANIP
$1.8B
| $633K | ﹤0.01% |
18,060
-3,609
| -17% | -$123K |
|
|
UBA
2713
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $633K | ﹤0.01% |
32,655
+10,202
| +45% | +$188K |
|
2714
Haverty Furniture Companies
HVT
$397M
| $631K | ﹤0.01% |
14,756
+2,750
| +23% | +$120K |
|
|
FFWM
2715
DELISTED
First Foundation Inc
FFWM
| $630K | ﹤0.01% |
27,966
| – | – |
|
2716
Curis
CRIS
$9.78M
| $629K | ﹤0.01% |
+195
| New | +$881K |
|
2717
Stoneridge
SRI
$195M
| $628K | ﹤0.01% |
21,300
-1,200
| -5% | -$38K |
|
|
GTS
2718
DELISTED
Triple-S Management Corporation
GTS
| $628K | ﹤0.01% |
28,201
| – | – |
|
2719
LifeMD
LFMD
$169M
| $627K | ﹤0.01% |
+53,266
| New | +$613K |
|
|
ATRS
2720
DELISTED
Antares Pharma, Inc.
ATRS
| $627K | ﹤0.01% |
143,900
+11,600
| +9% | +$47.3K |
|
2721
Core Laboratories
CLB
$488M
| $626K | ﹤0.01% |
16,063
+6,310
| +65% | +$226K |
|
2722
Expro Ltd
XPRO
$1.79B
| $625K | ﹤0.01% |
34,383
| – | – |
|
2723
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $623K | ﹤0.01% |
9,829
-77
| -0.8% | -$4.87K |
|
2724
Acco Brands
ACCO
$390M
| $619K | ﹤0.01% |
71,733
+7,228
| +11% | +$64.2K |
|
2725
Camden National
CAC
$978M
| $619K | ﹤0.01% |
12,966
-1,400
| -10% | -$66.5K |
|
Similar funds
AllianceBernstein's Q2 2021 Portfolio in Review
As of Q2 2021, AllianceBernstein held 3,558 positions worth $249B, up 9.2% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
AllianceBernstein's Q2 2021 filing shows 327 new, 1,436 increased, 1,300 reduced and 241 closed positions. Its largest new stake was Coinbase: 547,649 shares worth $139M. The largest sale was Regeneron Pharmaceuticals, an estimated $606M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2021 buy was Coinbase: 547,649 shares worth $139M.
- AllianceBernstein added most to Amazon in Q2 2021, an estimated $1.27B increase.
- AllianceBernstein's biggest Q2 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $606M.
- AllianceBernstein fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $43.3M.
- AllianceBernstein's ten largest holdings make up 24% of its $249B portfolio in Q2 2021.
- AllianceBernstein opened 327 new positions and closed 241 in Q2 2021.
- AllianceBernstein's portfolio value rose 9.2% quarter-over-quarter to $249B.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.